BlackRock
FLGT icon

BlackRock’s Fulgent Genetics FLGT Stock Holding History

BlackRock’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$44.1M Sell
2,774,519
-187,715
-6% -$4.07M ﹤0.01% 2586
2025
Q4 		$77.8M Sell
2,962,234
-13,177
-0.4% -$342K ﹤0.01% 2251
2025
Q3 		$67.2M Buy
2,975,411
+812,866
+38% +$16.7M ﹤0.01% 2328
2025
Q2 		$43M Sell
2,162,545
-82,010
-4% -$1.6M ﹤0.01% 2545
2025
Q1 		$37.9M Sell
2,244,555
-1,616,734
-42% -$27.5M ﹤0.01% 2527
2024
Q4 		$71.3M Sell
3,861,289
-61,724
-2% -$1.21M ﹤0.01% 2256
2024
Q3 		$85.2M Buy
3,923,013
+1,928
+0% +$43.1K ﹤0.01% 2177
2024
Q2 		$76.9M Buy
3,921,085
+547
+0% +$11.4K ﹤0.01% 2183
2024
Q1 		$85.1M Buy
3,920,538
+158,660
+4% +$3.94M ﹤0.01% 2147
2023
Q4 		$109M Buy
3,761,878
+156,307
+4% +$4.18M ﹤0.01% 2027
2023
Q3 		$96.4M Sell
3,605,571
-24,044
-0.7% -$821K ﹤0.01% 2015
2023
Q2 		$134M Sell
3,629,615
-16,805
-0.5% -$586K ﹤0.01% 1849
2023
Q1 		$114M Buy
3,646,420
+118,638
+3% +$3.82M ﹤0.01% 1933
2022
Q4 		$105M Buy
3,527,782
+43,443
+1% +$1.55M ﹤0.01% 1959
2022
Q3 		$133M Buy
3,484,339
+149,014
+4% +$7.47M ﹤0.01% 1769
2022
Q2 		$182M Buy
3,335,325
+40,971
+1% +$2.25M 0.01% 1596
2022
Q1 		$206M Sell
3,294,354
-126,897
-4% -$8.35M 0.01% 1657
2021
Q4 		$344M Buy
3,421,251
+50,770
+2% +$4.46M 0.01% 1318
2021
Q3 		$303M Buy
3,370,481
+313,166
+10% +$28.5M 0.01% 1400
2021
Q2 		$282M Buy
3,057,315
+471,185
+18% +$37.6M 0.01% 1520
2021
Q1 		$250M Buy
2,586,130
+601,263
+30% +$62.1M 0.01% 1572
2020
Q4 		$103M Buy
1,984,867
+398,049
+25% +$16.6M ﹤0.01% 2059
2020
Q3 		$63.5M Buy
1,586,818
+878,154
+124% +$27.5M ﹤0.01% 2152
2020
Q2 		$11.3M Buy
708,664
+558,435
+372% +$8.55M ﹤0.01% 3106
2020
Q1 		$1.62M Sell
150,229
-587
-0.4% -$8.18K ﹤0.01% 3721
2019
Q4 		$1.95M Buy
150,816
+135,102
+860% +$1.61M ﹤0.01% 3802
2019
Q3 		$164K Sell
15,714
-893
-5% -$8.47K ﹤0.01% 4352
2019
Q2 		$111K Buy
16,607
+2,281
+16% +$13.9K ﹤0.01% 4455
2019
Q1 		$86K Sell
14,326
-980
-6% -$4.49K ﹤0.01% 4396
2018
Q4 		$48K Sell
15,306
-280
-2% -$983 ﹤0.01% 4481
2018
Q3 		$61K Buy
15,586
+630
+4% +$2.7K ﹤0.01% 4525
2018
Q2 		$62K Sell
14,956
-601
-4% -$2.38K ﹤0.01% 4530
2018
Q1 		$62K Sell
15,557
-400
-3% -$1.76K ﹤0.01% 4414
2017
Q4 		$70K Buy
15,957
+640
+4% +$2.45K ﹤0.01% 4389
2017
Q3 		$74K Buy
15,317
+498
+3% +$2.86K ﹤0.01% 4411
2017
Q2 		$95K Sell
14,819
-123,920
-89% -$999K ﹤0.01% 4414
2017
Q1 		$1.51M Buy
+138,739
New +$1.64M ﹤0.01% 3731

Other funds holding FLGT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock's FLGT Position: Q1 2026 in Review

BlackRock reduced its Fulgent Genetics (FLGT) stake by 6.3% in Q1 2026, selling an estimated $4.07M and leaving 2,774,519 shares worth $44.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2586.

BlackRock first reported a position in FLGT in Q1 2017 and has held it in 37 quarters since. The position peaked at $344M in Q4 2021. 157 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • BlackRock held 2,774,519 shares of Fulgent Genetics worth $44.1M as of Q1 2026.
  • BlackRock sold 187,715 Fulgent Genetics shares in Q1 2026, an estimated $4.07M.
  • Fulgent Genetics made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #2586 holding.
  • BlackRock first reported a position in Fulgent Genetics in Q1 2017 and has held it in 37 quarters since.
  • BlackRock's Fulgent Genetics position peaked at $344M in Q4 2021.
  • 157 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.